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Abstract
Background:  An  inspiratory  capacity  to  total  lung  capacity  (IC/TLC)  ratio  of  ≤25%  has  emerged
as a  better  marker  of  mortality  in  chronic  obstructive  pulmonary  disease  (COPD)  patients.
The relationship  among  the  IC/TLC  ratio  to  lower  extremity  skeletal  muscle  function  remains
unknown.
Methods:  Thirty-ﬁve  men  with  moderate  to  severe  COPD  were  divided  into  those  with
IC/TLC ≤  25%  (n  =  16)  and  >25%  (n  =  19).  The  subjects  were  tested  for  thigh  muscle  mass  volume
(MMT), maximal  strength,  power  output  of  the  lower  extremities,  and  physical  activity.
Results: Total  MMT  in  the  IC/TLC  <  25%  group  was  signiﬁcantly  lower  (413.91  ±  89.42  cm3)
(p <  0.001)  than  in  the  IC/TLC  >  25%  group  (575.20  ±  11.76  cm3).  In  the  IC/TLC  ≤  25%  group,  max-
imal strength  of  the  lower  extremities  and  muscle  peak  power  output  of  the  lower  extremities
were 36--56%  lower  (p  <  0.01)  than  among  the  patients  in  the  IC/TLC  >  25%  group.
Conclusion:  IC/TLC  ≤  25%  is  associated  with  reduced  maximal  strength  and  peak  power  output
of the  lower  extremities.  IC/TLC  ≤  25%  may  have  an  important  clinical  relevance  as  an  index  to
determine  peripheral  muscle  dysfunction.
©  2016  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
o
p
i
anc-nd/4.0/).
Introduction
Skeletal  muscle  dysfunction  has  been  postulated  as  one
of  the  extrapulmonary  effects  in  patients  with  chronicPlease  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
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2173-5115/© 2016 Sociedade Portuguesa de Pneumologia. Published by 
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)bstructive  pulmonary  disease  (COPD),  resulting  in  reduced
eripheral  muscle  strength  and  muscle  mass.1,2 Reductions
n  muscle  force  production  contribute  to  exercise  intoler-
nce  and  have  been  associated  with  an  increased  mortality
isk  and  a  decrease  in  quality  of  life.3,4 Lower  extrem-ero  P,  et  al.  Rev  Port  Pneumol.  2016.
ty  muscle  power  has  been  also  recently  posited  as  a
ore  discriminating  variable  for  understanding  the  rela-
ionship  between  impairments,  functional  limitations,  and
Elsevier Espan˜a, S.L.U. This is an open access article under the CC
.
 IN+ModelR
2
r
t
f
t
a
f
f
v
m
H
s
b
R
(
i
e
e
I
c
I
i
m
t
v
I
s
p
t
c
p
u
I
t
t
M
S
T
o
p
i
G
m
a
i
s
i
t
n
m
c
e
t
o
H
P
B
b
t
a
a
T
M
n
G
t
s
a
i
1
C
5
T
c
P
H
e
a
m
e
L
p
O
l
m
G
w
a
w
t
(
w
d
w
T
f
UARTICLEPPNEN-1189; No. of Pages 7
 
esultant  disability  with  aging.5,6 Physical  inactivity  and  sys-
emic  inﬂammation  have  been  cited  as  factors  responsible
or  muscle  dysfunction  in  COPD.7,8 Considering  that  reduc-
ions  in  peripheral  muscle  strength  have  important  clinical
nd  functional  implications  for  COPD  patients,  the  search
or  effective  pulmonary  indices  to  predict  peripheral  muscle
unction  is  of  paramount  importance.
Among  the  pulmonary  parameters,  forced  expiratory
olume  in  1  second  (FEV1)  is  the  most  important  spiro-
etric  indicator  of  the  severity  of  airﬂow  obstruction.
owever,  several  studies  have  shown  the  weak  relation-
hip  between  FEV1 and  mortality,9,10 indeed,  it  cannot
e  used  to  detect  abnormal  skeletal  muscle  function.
ecently,  the  inspiratory  capacity-to  total  lung  capacity
IC/TLC)  ratio  has  emerged  as  a  better  marker  of  mortal-
ty  and  functional  reserve  and  is  associated  with  altered
xercise  capacity  in  COPD  patients.11,12 Recently,  Ramon
t  al.13 observed  that  the  patients  with  COPD  with  lower
C/TLC  experience  a  higher  longitudinal  decline  in  exercise
apacity.
To  date,  only  one  study  has  investigated  the  role  of
C/TLC  ratio  on  the  muscle  function  in  the  upper  extrem-
ties  in  this  population  of  patients.  Its  authors  found  that
aximal  hand  grip  strength  was  lower  among  IC/TLC  ≤  25%
han  among  patients  with  IC/TLC  >  25%.14 However,  no  pre-
ious  studies  have  established  the  correlation  between  the
C/TLC  ratio  and  lower  extremity  muscle  mass,  maximal
trength,  and  muscle  peak  power  output  in  this  patient
opulation.
Accordingly,  the  primary  aim  of  the  present  study  was
o  determine  whether  the  inspiratory  capacity-to-total  lung
apacity  ratio  or  inspiratory  fraction  would  be  useful  in
redicting  skeletal  muscle  dysfunction  in  the  lower  and
pper  extremities.  We  hypothesized  that  patients  with
C/TLC  ≤  25%  would  have  less  maximal  muscle  strength  of
he  lower  and  upper  extremities  and  peak  power  output  of
he  lower  limbs  than  IC/TLC  >  25%  patients.
aterials and methods
ubjects
hirty-ﬁve  men  with  stable  COPD  were  recruited  via  an
utpatient  clinic  through  the  local  pulmonologist  ofﬁce  to
articipate  in  the  study.  All  patients  had  received  a  clin-
cal  and  functional  diagnosis  of  COPD  according  to  the
OLD  criteria  (stages  II  and  III).  Patients  presented  with
oderate-to-severe  airways  obstruction  (FEV1/FVC  <  0.7
nd  FEV1 <  80%  but  FEV1 >  30%  predicted).  Inclusion  criteria
nclude:  (1)  dyspnea  (mMMRC  grades  II  and  III);  (2)  ex-
mokers  status;  and  (3)  aged  60--80  yrs.  Exclusion  criteria
nclude:  (1)  having  never  smoked;  (2)  exacerbation  of  symp-
oms  in  the  preceding  three  months;  and  (3)  cardiovascular,
euromuscular,  musculoskeletal  or  arthritic  problems  that
ight  limit  exercise  tolerance.  The  patients  were  informed
arefully  about  the  procedures  and  possible  risks  of  thePlease  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
xperiments,  as  well  as  the  beneﬁts  of  the  project,  and  writ-
en  consent  was  obtained.  The  Research  Ethics  Committees
f  the  Public  University  of  Navarre  and  Virgen  del  Camino
ospital  approved  the  study.
O
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ulmonary  functional  and  clinical  assessments
aseline  assessment  included:  (1)  spirometry,  lung  volumes
y  body  plethysmography,  maximal  inspiratory  and  expira-
ory  pressure  according  with  recommended  methods;  (2)
nthropometric  variables;  (3)  6-min,  walk  test  (6MWT)15;
nd  (4)  BODE  index.
high  muscle  mass
uscle  mass  (MM)  of  the  thigh  (T)  were  assessed  using  mag-
etic  resonance  imaging  (MRI;  1.5  T;  Siemens  Magnetom,
ermany).  The  length  of  the  femur  (Lf),  taken  as  the  dis-
ance  from  the  intercondylar  notch  of  the  femur  to  the
uperior  boundary  of  the  femoral  head  was  measured  on
 coronal  plane.  Subsequently,  15  axial  scans  of  the  thigh
nterspaced  by  a distance  of  1/15  Lf  were  obtained  from
/15  Lf  to  15/15  Lf.  MR  imaging  of  both  thighs  was  obtained.
ross-sectional  volumes  (cm3)  of  the  thigh  at  30%  proximal,
0%,  and  70%  distal  of  the  Lf  were  used  for  further  analysis.
he  total  volume  (cm3)  of  the  MMT was  calculated  as  the
ombination  of  the  30,  50,  and  70%  of  the  Lf.16
hysical  activity
abitual  physical  activity  was  evaluated  using  accelerom-
try  (TriTrac-R3D  system;  WI,  USA).  The  TriTrac  was  worn
round  the  waist.  TriTrac  monitoring  was  recorded  on  a
inute-by-minute  basis  during  two  weekdays  and  two  week-
nd  days.
ower  extremity  maximal  strength  and  muscle
eak power  output
ne  repetition  maximum  (the  heaviest  load  that  could  be
ifted  only  once  using  the  correct  technique)  was  deter-
ined  for  the  leg  press  exercise  (1RMLP) (Technogym,
ambettola,  Italy).  Three-to-four  subsequent  attempts
ere  made  to  determine  1RM.16
The  subjects  were  instructed  to  exert  their  maximal  force
s  fast  as  possible.
Muscle  peak  power  output  of  the  leg  extensor  muscles
as  measured  during  the  concentric  phase  of  leg  press  using
he  load  equal  to  50  and  70%  of  1RM.  An  optical  encoder
Computer  Optical  Products  Inc.,  CA,  USA)  was  attached  to
eight  plates  to  record  the  position  and  direction  of  the
isplacement  to  an  accuracy  of  0.2  mm  at  1000  Hz.  Subjects
ere  instructed  to  displace  the  weights  as  fast  as  possible.
wo  testing  trials  were  recorded  and  the  best  trial  was  taken
or  further  analysis.
pper  extremity  maximal  strengthero  P,  et  al.  Rev  Port  Pneumol.  2016.
ne  repetition  maximum  (1RM)  was  determined  for  seated
hest  press  (1RMCP),  shoulder  press,  and  seated  row  (Techn-
gym,  Gambettola,  Italy).16
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Inspiratory  fraction  and  muscle  dysfunction  in  COPD  patient
Systemic  inﬂammation
After  10  h  of  fasting  and  1  day  of  minimal  physical  activ-
ity,  venous  blood  samples  were  obtained  at  rest  between  8
and  10  a.m.  from  the  antecubital  vein  for  the  determina-
tion  of  interleukin-6  (IL-6),  tumor  necrosis  factor    (TNF-),
C-reactive  protein  (CRP),  and  plasma  vascular  endothelial
growth  factor  A  (VEGF-A)  concentrations.  Circulating  con-
centrations  of  IL-6,  TNF-, CRP,  and  VEGF-A  were  assessed
in  duplicate  using  commercially  available  enzyme-linked
immune  absorbent  assay  and  radioimmunoassay  kits.
Statistical  analysis
Standard  statistical  methods  were  used  to  calculate  mean
and  standard  deviations  (SPSS,  Chicago,  Illinois).  Statistical
treatment  was  performed  using  SPSS  program  version  23.0.
The  assumption  of  a  normal  distribution  of  the  data  was  eval-
uated  with  a  Shapiro--Wilk  test.  Cross-sectional  comparisons
between  groups  were  performed  by  either  a  parametricPlease  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
(unpaired  t-test)  or  a  non-parametric  test  (Mann--Whitney
U  test).  Pearson  product-moment  or  Rho  Spearman  corre-
lation  coefﬁcients  were  used  to  determine  the  association
between  variables  of  interests.  Due  to  the  small  size  of
p
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Table  1  Clinical,  anthropometric  characteristics  and  inﬂammat
disease according  to  inspiratory  capacity  to  total  lung  capacity  rat
IC/TLC  ≤  25%  
Subjects,  n  16  
Age, y  71  ±  5  
Body mass,  kg  70.4  ±  12.6  
Height, cm  166  ±  6.1  
BMI, kg  m−2 25.3  ±  3.7  
FEV1,  %  predicted  37.67  ±  7.92  
FVC, %  predicted  67.02  ±  14.14  
FEV1/FVC,  %  41  ±  8.9  
TLC, %  predicted  120.09  ±  21.2  
RV, %  predicted  177.69  ±  41.1  
RV/TLC, %  61.95  ±  7.36  
IC, L  1.54  ±  0.4  
IC/TLC, %  20  ±  3.96  
PI,max, cmH20  69.38  ±  21  
PE,max, cmH20  89.81  ±  37.1  
6MWT, m  409  ±  108  
Final Borg  dyspnea  in  the  6MWT,  score  4.34  ±  2.49  
Final SpO2 in  the  6MWT  (%)  82  ±  7.54  
Change SpO2 in  6MWT,  points 9.87  ±  6.24  
BODE index 4.4  ±  1.4
IL-6, g  mL−1 14.42  ±  17.14  
VEGF-A, g  mL−1 168.21  ±  295.09  
TNF-, g  mL−1 15.38  ±  6.83  
CRP, mg  dL−1 2.33  ±  3.47  
Values expressed in mean ± SD. BMI = body mass index; FEV1 = forced
TLC = total lung capacity; RV = residual volume; IC = inspiratory capacity
ratory pressure; SpO2 = arterial oxygen saturation measured by pulse 
6MWT. PRESS
3
he  sample,  the  p-value  was  simulated  using  bootstrap
ethod  with  replacement  procedure  as  part  of  the  analy-
is.  A  random  sample  was  designed  with  replacement  from
he  original  sample  to  produce  a  new  sample  of  the  same
ize  as  the  original.  This  procedure  was  repeated  for  each
ample  separately,  and  the  difference  in  mean  calculated.
his  procedure  was  repeated  1000  times.  The  p  <  0.05  crite-
ion  was  used  to  establish  statistical  signiﬁcance.  Values  are
eported  as  mean  values  ±  standard  deviations  (SD).
esults
linical  characteristics  and  physical  activity
linical  characteristics  according  to  the  IC/TLC  ratio  are
hown  in  Table  1.  The  6MWT  distance  was  lower  (p  =  0.001;
ootstrap  p  <  0.001)  and  the  BODE  index  was  higher
p  =  0.001;  bootstrap  p  <  0.001)  in  the  IC/TLC  ≤  25%  group.
L-6  and  CRP  concentrations  were  higher  (p  <  0.05;  bootstrapero  P,  et  al.  Rev  Port  Pneumol.  2016.
 <  0.01)  in  the  IC/TLC  ≤  25%  group.  Habitual  physical  activ-
ty  during  the  four  days  was  23%  lower  (7228  ±  1459  kcal
s.  9250  ±  1952  kcal,  p  <  0.01;  bootstrap  p  <  0.001)  in  the
C/TLC  ≤  25%  group  than  in  the  IC/TLC  >  25%  group.
ory  markers  in  patients  with  chronic  obstructive  pulmonary
io.
IC/TLC  >  25%  p-Value  Bootstrap
p-Value
19
68  ±  5  0.11  0.12
83.4  ±  18.8  0.03  0.01
167  ±  6.5  0.70  0.76
29.6  ±  5.3  <0.01  <0.001
48.9  ±  11.03  <0.01  0.002
77.69  ±  13.39  0.06  0.01
45  ±  9  0.13  0.12
115.53  ±  18.13  0.50  0.52
153.24  ±  8.75  0.07  0.06
52.21  ±  7.98  0.001  <0.001
2.52  ±  1.03  <0.001  <0.001
35.47  ±  11.57  <0.001  <0.001
89.16  ±  25.67  0.02  <0.01
101.11  ±  28.57  0.16  0.33
528  ±  74  0.001  <0.001
4.11  ±  1.84  0.76  0.76
83  ±  8.20  0.68  0.70
10.88  ±  8.21  0.69  0.68
2.7  ±  0.9  0.001  <0.001
4.86  ±  3.18  <0.05  <0.01
82.36  ±  70.36  0.14  0.18
16.98  ±  8.07  0.54  0.53
0.59  ±  0.64  <0.05  <0.01
 expiratory volume in one second; FVC = forced vital capacity;
; PI,max = maximal inspiratory pressure; PE,max = maximal expi-
oximetry; Change SpO2 = SpO2 before minus SpO2 at the end of
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Figure  1  Thigh  muscle  mass  (MMT)  at  30%,  50%,  and  70%  Lf
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lccording  to  IC/TLC  ratio.  Data  are  presented  as  means  ±  SD.
p ≤  0.001  IC/TLC  ≤  25%  vs.  IC/TLC  >  25%.
high  muscle  mass
MT volume  at  30%,  50%,  and  70%  Lf  were  lower  (p  ≤  0.001;
ootstrap  p  <  0.001)  in  the  IC/TLC  ≤  25%  group  than  in
he  IC/TLC  > 25%  group  (Fig.  1).  Total  MMT volume  was
ower  (p  <  0.001;  bootstrap  p  <  0.001)  in  the  IC/TLC  ≤  25%
roup  (413.91  ±  89.42  cm3)  than  in  the  IC/TLC  >  25%  group
575.20  ±  115.25  cm3).
ower  extremity  maximal  dynamic  strength  and
uscle peak  power  output
he  1RMLP exercise  was  36%  lower  (p  <  0.00;  bootstrap
 <  0.001)  in  the  IC/TLC  ≤  25%  group  (Fig.  2).  Interestingly,Please  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
hen  maximal  bilateral  concentric  strength  were  expressed
elative  to  total  MMT volume,  the  differences  between
he  groups  disappeared  (0.36  ±  0.06  vs.  0.35  ±  0.08  kg  cm−3,
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5igure  3  Relationship  between  IC/TLC  ratio  and  total  MMT in
atients  with  IC/TLC  ≤  25%  ()  and  IC/TLC  >  25%  ().
 = 0.70;  bootstrap  p  =  0.73)  in  the  IC/TLC  ≤  25%  and
C/TLC  >  25%,  respectively.
Lower  extremities  muscle  peak  power  output  at  50  and
0%  of  1  RM  was  43%  (495  ±  192  vs.  711  ±  216  W,  p  <  0.0;
ootstrap  p  <  0.001)  and  56%  (390  ±  168  vs.  612  ±  211  W;
 < 0.01;  bootstrap  p  <  0.001)  lower  in  the  IC/TLC  ≤  25%
roup,  respectively.  When  muscle  peak  power  output  was
xpressed  relative  to  kilogram  of  body  mass,  the  differ-
nce  was  reduced  to  26%  at  the  load  of  50%  (6.89  ±  1.95
s.  8.74  ±  2.77  W  kg−1,  p  =  0.032;  bootstrap  p  =  0.014)  and
6%  at  the  load  of  70%  (5.48  ±  1.86  vs.  7.48  ±  2.39  W  kg−1,
 = 0.01;  bootstrap  p  =  0.002)  in  the  IC/TLC  ≤  25%  than  in
he  IC/TLC  >  25%  group,  respectively.  When  muscle  peak
ower  output  was  expressed  relative  to  total  MMT volume,
he  differences  between  the  groups  were  abolished  at  the
oad  of  50%  of  1RM  (1.2  ±  0.3  vs.  1.3  ±  0.3  W  cm−3, p  =  0.35;
ootstrap  p  =  0.70)  in  the  IC/TLC  ≤  25%  compared  with  the
C/TLC  >  25%,  respectively.
pper  extremity  maximal  dynamic  strength
he  1RMCP was  42%  lower  (p  <  0.001;  bootstrap  p  <  0.001)
n  the  IC/TLC  ≤  25%  group  (Fig.  2).  Maximal  dynamic
trength  1RM  in  the  seated  row  and  shoulder  press  was  25%
ower  (42.03  ±  7.5  vs.  52.63  ±  8.2  kg;  p  <  0.001;  bootstrap
 < 0.001)  and  29%  lower  (47.86  ±  9.9  vs.  62.10  ±  15.6  kg,
 = 0.003;  bootstrap  p  = 0.002)  in  the  IC/TLC  ≤  25%  group
han  in  the  IC/TLC  >  25%  group,  respectively.
ssociations
he  IC/TLC  ratio  was  positively  associated  with  total
MT volume  (Fig.  3),  1RMLP (r  =  0.57;  p  =  0.001),  1RMCP
r  =  0.60;  p  <  0.001)  and  physical  activity  (r  =  0.55;  p  =  0.001)
or  the  entire  group.  The  FEV1 (%  predicted)  was  posi-
ively  associated  with  total  MMT volume  (r  =  0.46;  p  <  0.01),
RMLP (r  =  0.43;  p  =  0.01),  and  physical  activity  (r  =  0.54;ero  P,  et  al.  Rev  Port  Pneumol.  2016.
 = 0.001)  for  the  entire  group.  Moreover,  physical  activity
as  positively  associated  with  total  MMT volume  (r  =  0.81;
 < 0.001),  1RMLP (r  =  0.62;  p  <  0.001),  and  muscle  power  at
0%  1RM  (r  =  0.78;  p  <  0.001).  In  addition,  a  negative  linear
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relationship  was  found  between  IL-6  and  MMT  volume
(r  =  −0.40;  p  =  0.02),  1RMLP (r  =  −0.50;  p  <  0.01)  and  mus-
cle  power  at  50%  of  1RM  (r  =  −0.46;  p  <  0.01)  for  the  entire
group.
Discussion
The  salient  ﬁndings  of  this  study  were  that  thigh  muscle
mass,  lower  and  upper  maximal  strength,  and  leg  mus-
cle  peak  power  output  was  reduced  signiﬁcantly  in  COPD
patients  with  IC/TLC  ≤  25%.  In  addition,  the  IC/TLC  a  pre-
dictor  of  mortality,  was  related  to  thigh  muscle  mass  and
the  maximal  strength  of  lower  and  upper  extremities.  The
present  ﬁndings  suggest  that  IC/TLC  ≤  25%  may  be  valued  as
an  applicable  index  of  skeletal  muscle  dysfunction  in  chronic
obstructive  pulmonary  disease  patients.
An  inspiratory-to  total  lung  capacity  ratio  of  ≤25%  is  an
important  independent  predictor  of  increased  mortality.11
Recently,  Ramon  et  al.13 observed  that  the  patients  with
COPD  with  lower  IC/TLC  experience  a  higher  longitudinal
decline  in  exercise  capacity  and  IC/TLC  and  dyspnea  in
clinically  stable  patients  with  COPD  predict  their  exercise
capacity.
On  the  basis  of  previous  studies  suggesting  that  lower  fat-
free  mass  and  reduced  grip  strength  is  related  to  an  IC/TLC
of  ≤25%,14 we  sought  to  determine  whether  an  IC/TLC  of
≤25%  would  translate  to  unfavorable  changes  in  muscle
mass  and  muscle  function  (maximal  strength  and  power  out-
put  normalized  to  muscle  cross-sectional  area)  in  the  lower
extremities.  Skeletal  muscle  weakness  in  the  lower  extrem-
ities  has  previously  been  shown  to  be  more  established
with  the  increase  of  the  dyspnea,  BODE  index  score,  and
disease  severity  in  COPD  patients.17 Previous  studies  have
observed  that  reduced  thigh  muscle  cross-sectional  area3
and  reduced  maximal  quadriceps  strength,1 which  result  in
an  impaired  functional  capacity,18 is  related  to  increased
mortality19 and  health  care  utilization.4 Recently,  it  has  been
also  reported  that  lower  extremity  muscle  power  remains  as
a  more  discriminating  variable  for  understanding  the  rela-
tionships  between  impairments,  functional  limitations,  and
resultant  disability  with  aging.5,6 However,  no  previous  study
has  determined  that  the  IC/TLC  ratio  is  a  marker  of  muscle
atrophy  and  reduced  maximal  strength  and  muscle  power
output  in  the  lower  limbs  in  COPD  patients.
A  unique  ﬁndings  in  this  present  study  was  that  thigh
muscle  mass  and  maximal  dynamic  strength  in  the  lower
limbs  were  lower  in  the  IC/TLC  ≤  25%  group.  This  hypothesis
was  strengthened  by  the  relationship  observed  between  the
IC/TLC  and  muscle  mass  (r  =  0.67;  p  <  0.001)  and  lower  max-
imal  strength  (r  =  0.57;  p  <  0.01).  In  this  study,  we  extended
our  investigation  by  determining  the  relationship  between
the  IC/TLC  >  25%  group  and  the  maximal  strength  of  the
upper  limbs.  Indeed,  reduced  maximal  strength  in  the  upper
extremities  was  found  in  the  IC/TLC  ≤  25%  group.  This  sug-
gests  that  the  inspiratory-to-total  lung  capacity  ratio  of
≤25%  is  a  surrogate  marker  of  thigh  muscle  atrophy  and
peripheral  skeletal  muscle  weakness.Please  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
Recently,  impairments  in  muscle  peak  power  output  in
the  lower  extremity  have  emerged  as  a  more  important  pre-
dictor  of  limitations  in  mobility  in  tasks  such  as  rising  from  a
chair,  climbing  stairs,  habitual  walking  speed,  and  even  the
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revention  of  falls,  than  maximal  muscle  strength  in  older
dults.20--24 To  the  best  of  our  knowledge,  this  is  the  ﬁrst
tudy  to  report  the  association  between  the  IC/TLC  ratio  and
ower  extremity  muscle  peak  power  in  patients  with  COPD.
ur  results  indicate  that  muscle  peak  power  output  at  50
nd  70%  of  1RM  is  reduced  in  COPD  patients  with  an  IC/TLC
f  ≤25%.  Furthermore,  a  slowed-down  capacity  for  muscle
ower  output  and  delayed  responsiveness  to  accidental  falls
n  the  lower  and  upper  limbs  is  associated  with  disability.5,6
t  has  been  documented  that  in  older  adults25 with  lower
xtremity  power  at  high  velocities  (40%  1RM)  contractions
ere  a  better  predictor  of  habitual  gait  velocity  than  power
t  low  velocities  (70%  1RM).  One  of  the  major  ﬁndings  in  this
tudy  was  that  when  maximal  bilateral  dynamic  strength  and
uscle  power  output  were  expressed  relative  to  total  MMT,
he  differences  between  the  groups  disappeared.  This  sug-
ests  that  the  impairment  in  peripheral  muscle  function  of
he  lower  limbs  in  patients  with  IC/TLC  ≤  25%  is  mainly  due
o  loss  of  muscle  mass  and  that  neural  activation  patterns
nd/or  twitch  tension  per  muscle  mass  volume  under  max-
mal  concentric  actions  (typical  leg  extension  actions  also
n  normal  daily  activities)  could  be  rather  similar  between
roups.
It  is  no  clear  which  physiological  mechanisms  explained
he  reductions  in  muscle  mass  in  COPD  patients  with  an
C/TLC  of  ≤25%.  In  healthy  older  adults,  reduced  maximal
trength  has  been  attributed  to  a  great  extent  to  the  reduc-
ion  in  muscle  mass,  which  is  perhaps  related  to  alterations
n  hormone  balance26 and  the  decline  in  the  quantity  and
ntensity  of  physical  activity.27 In  this  context,  we  postu-
ated  that  lower  limb  muscle  mass  and  reductions  in  maximal
trength  and  peak  power  output  might  be  due  to  elevated
nﬂammation  and  the  physical  inactivity  associated  with  the
ystemic  inﬂammation.28,29 Consistent  with  the  ﬁrst  part
f  the  hypothesis,  we  found  that  patients  with  an  IC/TLC
f  ≤25%  have  elevated  CRP  and  IL-6  levels  and  also,  we
bserved  a  negative  relationship  between  IL-6  and  muscle
ass,  lower  extremity  maximal  dynamic  strength  and  leg
uscle  peak  power  output.  Therefore,  the  present  results
ight  indicate  that  the  effects  of  circulating  IL-6  may  be
ssociated  with  reduced  muscle  mass  and  skeletal  muscle
eakness.  The  results  contradict  the  ﬁndings  of  Pleguezue-
os  et  al.30 who  did  not  observe  any  signiﬁcant  relationship
etween  quadriceps  strength  and  IL-6.  These  differences
ight  occur  because  of  the  maximum  strength  measurement
i.e.,  dynamic  maximum  test  vs.  isokinetic  test).  Previous
tudies  have  shown  that  higher  levels  of  systemic  inﬂamma-
ion  are  associated  with  reduced  physical  activity  in  patients
ith  COPD,7 and  the  older  adults  who  are  physically  inac-
ive  have  higher  levels  of  systemic  inﬂammatory  markers
han  those  who  are  physically  active.31 In  support  of  the
econd  part,  the  IC/TLC  ≤  25%  group  demonstrated  a  23%
ower  habitual  physical  activity.  Moreover,  physical  activ-
ty  was  positively  associated  with  lower  extremity  maximal
trength,  muscle  power  output,  and  thigh  muscle  mass  in  the
ooled  group.  In  the  present  study,  IC/TLC  ratio  was  posi-
ively  associated  with  physical  activity  (r  =  0.55;  p  =  0.001)
or  the  entire  group,  suggesting  that  those  patients  with
igher  static  hyperinﬂation  (low  IC/TLC)  are  less  physicallyero  P,  et  al.  Rev  Port  Pneumol.  2016.
ctive.  A  limitation  of  our  study  is  that  there  was  no  direct
ynamic  hyperinﬂation  during  the  6MWT  measurements.
arcia-Rio  et  al.32 have  reported  that  the  reduced  daily
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hysical  activity  of  patients  with  moderate-severe  COPD
ight  be  partially  explained  by  the  development  of  dynamic
yperinﬂation,  regardless  of  the  severity  of  the  disease.
arcia-Rio  et  al.32 have  showed  that  the  increase  in  EELV
uring  exercise  was  associated  with  dyspnea  as  evaluated
y  the  MRC  scale.  This  breathlessness  could  promote  the
imitation  when  the  patients  performed  their  daily  physi-
al  activity,  increasing  the  physical  inactivity.  At  the  same
ime,  this  physical  inactivity  could  contribute  to  the  weak-
ess  and  atrophy  of  the  muscles,  leading  to  a  vicious  circle
hat  causes  more  physical  inactivity,  atrophy  and  skeletal
uscle  dysfunction.
There  are  several  methodological  limitations  in  our
xperimental  approach.  First,  as  the  size  of  the  sample
n  the  study  was  small,  we  used  the  bootstrapping  proce-
ure  as  part  of  the  statistical  analysis,  strengthening  our
esults.  Second,  we  did  not  take  into  account  patients  who
eceived  corticosteroids.  Previous  studies1 have  shown  that
uadriceps  strengthened  but  thigh  muscle  mass  was  lower  in
hose  patients  who  received  systemic  corticosteroids.  How-
ver,  the  patients  in  our  study  received  the  same  medical
reatment  and  exacerbation  was  an  exclusion  criteria.
In  conclusion,  the  results  of  this  study  indicate  that  the
nspiratory-to  total  lung  capacity  ratio  may  be  an  effective
ulmonary  measurement  to  determine  muscle  atrophy  in  the
ower  extremities  and  skeletal  muscle  dysfunction.  The  rela-
ionship  observed  is  clinically  important  because  an  IC/TLC
f  ≤25%  can  be  used  as  an  index  to  detect  skeletal  muscle
eakness.
thical responsibilities
rotection  of  human  and  animal  subjects.  The  authors
eclare  that  the  procedures  followed  were  in  accordance
ith  the  regulations  of  the  relevant  clinical  research  ethics
ommittee  and  with  those  of  the  Code  of  Ethics  of  the  World
edical  Association  (Declaration  of  Helsinki).
onﬁdentiality  of  data.  The  authors  declare  that  they  have
ollowed  the  protocols  of  their  work  center  on  the  publica-
ion  of  patient  data.
ight  to  privacy  and  informed  consent.  The  authors  have
btained  the  written  informed  consent  of  the  patients  or
ubjects  mentioned  in  the  article.
onﬂict of interest
he  authors  declare  that  there  is  no  conﬂict  of  interest.Please  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
cknowledgments
his  study  was  conducted  with  the  support  of  the  Span-
sh  Ministry  of  Education  and  Science  (Plan  Nacional  I  +  D  +  i
004-2007  y  2008-20011  Strategic  action:  ‘‘Sport  and  phys-
cal  education’’  Ref:  DEP2007-73220,  DEP2011-30042)  and
ealth  Sciences  Department  of  Government  of  Navarre.
1
1 PRESS
P.  Cebollero  et  al.
eferences
1. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau
R, et al. Peripheral muscle weakness in patients with chronic
obstructive pulmonary disease. Am J Respir Crit Care Med.
1998;158:629--34.
2. Gosker HR, Kubat B, Schaart G, Van der Vusse GJ, Wouters
EF, Schols AM. Myopathological features in skeletal muscle of
patients with chronic obstructive pulmonary disease. Eur Respir
J. 2003;22:280--5.
3. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier
G, et al. Midthigh muscle cross-sectional area is better predic-
tor of mortality than body mass index in patients with chronic
obstructive pulmonary disease. Am J Respir Crit Care Med.
2002;166:809--13.
4. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers
G. Muscle weakness is related to utilization of health care
resources in COPD patients. Eur Respir J. 1997;10:417--23.
5. Reid KF, Fielding RA. Skeletal muscle power and functioning in
older adults. Exerc Sport Sci Rev. 2012;40:1--12.
6. Cadore EL, Izquierdo M. How to simultaneously optimize muscle
strength, power, functional capacity, and cardiovascular gains
in the elderly: an update. Age. 2013;35:2329--44.
7. Watz H, Waschki B, Boeheme C, Claussen M, Meyer T, Magnussen
H. Extrapulmonary effects of chronic obstructive pulmonary dis-
ease on physical activity: a cross-sectional study. Am J Respir
Crit Care Med. 2008;177:743--51.
8. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gos-
selink R. Characteristic of physical activity in daily life in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med.
2005;171:972--7.
9. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan
M. Pulmonary function is a long-term predictor of mortality in
the general population: 29-year follow-up of the Buffalo Health
Study. Chest. 2000;118:656--64.
0. Celli BR. Predictors of mortality in COPD. Respir Med.
2010;104:773--9.
1. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM,
Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio pre-
dicts mortality in patients with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med. 2005;171:591--7.
2. Alburquerque ALP, Nery LE, Villac¸a DS, Machado TY, Oliveira CC,
Paes AT, et al. Inspiratory fraction and exercise impairment in
COPD patients GOLD stages II--III. Eur Respir J. 2006;28:939--44.
3. Ramon MA, Ferrer J, Gimeno-Santos E, Donaire-Gonzalez D,
Rodríguez E, Balcells E, et al. Inspiratory capacity-to-total lung
capacity ratio and dyspnoea predict exercise capacity decline
in COPD. Respirology. 2016;21:476--82.
4. Vassaux C, Torre-Bouscoulet L, Zeineldine Z, Cortopassi F, Paz-
Díaz H, Celli BR, et al. Effects of hyperinﬂation on the oxygen
pulse as a marker of cardiac performance in COPD. Eur Respir
J. 2008;32:1275--82.
5. ATS. ATS statement: guidelines for the six-minute walk test. Am
J Respir Crit Care Med. 2002;166:111--7.
6. Izquierdo M, González-Izal M, Navarro-Amezqueta I, Calbet JA,
Iban˜ez J, Malanda A, et al. Effects of strength training on muscle
fatigue mapping from surface EMG and blood metabolites. Med
Sci Sports Exerc. 2011;43:303--11.
7. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD,
Jackson A, et al. The prevalence of quadriceps weakness in
COPD and the relationship with disease severity. Eur Respir J.
2010;36:81--8.
8. Gosselink R, Troosters T, Decramer M. Peripheral muscle weak-ero  P,  et  al.  Rev  Port  Pneumol.  2016.
ness contributes to exercise limitation in COPD. Am J Respir Crit
Care Med. 1996;153:976--80.
9. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti
EJ, et al. Quadriceps strength predicts mortality in patients
 IN+Model
s  
2
2
2
2
3
3
3
Collazo E, et al. Daily physical activity in patients withARTICLERPPNEN-1189; No. of Pages 7
Inspiratory  fraction  and  muscle  dysfunction  in  COPD  patient
with moderate to severe chronic obstructive pulmonary disease.
Thorax. 2007;62:115--20.
20. Izquierdo M, Aguado X, Gonzalez R, López JL, Häkkinen K.
Maximal and explosive force production capacity and balance
performance in men of different ages. Eur J Appl Physiol.
1999;79:260--7.
21. Izquierdo M, Iban˜ez J, Gorostiaga E, Garrues M, Zun˜iga A, Antón
A, et al. Maximal strength and power characteristics in isomet-
ric and dynamic actions of the upper and lower extremities in
middle-aged and older men. Acta Physiol Scand. 1999;167:57--8.
22. Bassey EJ, Fiatarone MA, O’Neill EF, Kelly M, Evans WJ, Lipsitz
LA. Leg extensor power and functional performance in very old
men and women. Clin Sci. 1992;82:321--7.
23. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Fer-
ruci L. A comparison of leg power and leg strength within the
InCHIANTI study: which inﬂuences mobility more? J Gerontol A
Biol Sci Med Sci. 2003;58:728--33.
24. Bottaro M, Machado SN, Nogueira W, Scales R, Veloso J. Effect of
high versus low-velocity resistance training on muscular ﬁtness
and functional performance in older men. Eur J Appl Physiol.
2007;99:257--64.Please  cite  this  article  in  press  as:  Ceboll
http://dx.doi.org/10.1016/j.rppnen.2016.07.003
25. Cuoco A, Callahan DM, Sayers S, Frontera WR, Bean J, Fielding
RA. Impact of muscle power and force on gait speed in dis-
abled older men and women. J Gerontol A Biol Sci Med Sci.
2004;59:1200--6. PRESS
7
6. Häkkinen K, Pakarinen A. Serum hormones and strength devel-
opment during strength training in middle-aged and elderly
males and females. Acta Physiol Scand. 1994;150:211--9.
7. Mälkiä E, Impivaara O, Heliövaara M, Maatela J. The physi-
cal activity of healthy and chronically ill adults in Finland at
work, at leisure and during commuting. Scand J Med Sci Sports.
1994;4:82--7.
8. Agusti AGN, Noguera A, Sauleda J, Sala E, Pons J, Busquests X.
Systemic effects of chronic obstructive pulmonary disease. Eur
Respir J. 2003;21:347--60.
9. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise
tolerance, and COPD: is systemic inﬂammation the missing link.
Thorax. 2006;61:1--3.
0. Pleguezuelos E, Esquinas C, Moreno E, Guirao L, Ortiz J, Garcia-
Alsina J, et al. Muscular dysfunction in COPD: Systemic effect
or deconditioning. Lung. 2016;194:249--57.
1. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M,
Lennon L. Physical activity and hemostatic and inﬂammatory
variables in elderly men. Circulation. 2002;105:1785--90.
2. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, López-ero  P,  et  al.  Rev  Port  Pneumol.  2016.
chronic obstructive pulmonary disease is mainly associated
with dynamic hyperinﬂation. Am J Respir Crit Care Med.
2009;180:506--12.
